Market Overview The US Allergy Vaccine Market is advancing rapidly in food allergy indications, with peanut oral immunotherapy leading a pipeline that promises to transform anaphylaxis prevention. The US Allergy Vaccine Market is projected to grow through 2030, driven by Palforzia peanut powder approval, epicutaneous patch development, multi-food immunotherapy trials, and increasing investment...